o2hdiscovery.co Open in urlscan Pro
13.41.240.231  Public Scan

Form analysis
3 forms found in the DOM

GET https://o2hdiscovery.co/

<form class="search-wrapper desktop-search search-form" role="search" method="get" action="https://o2hdiscovery.co/">
  <input class="first-input search-field" type="search" placeholder="Enter CAS No., CAT. Or Product Name" id="search-form-1" value="" name="s">
  <input type="image" src="https://o2hdiscovery.co/wp-content/themes/o2hdiscoverywebsite1/assets/images/icon/search-icon.svg" alt="Submit" class="search-icon" value="Search">
</form>

GET https://o2hdiscovery.co/

<form class="search-wrapper catalog-mobile-search search-form" role="search" method="get" action="https://o2hdiscovery.co/">
  <input class="first-input search-field" type="search" placeholder="Enter CAS No., CAT. Or Product Name" id="search-form-1" value="" name="s">
  <input type="image" src="https://o2hdiscovery.co/wp-content/themes/o2hdiscoverywebsite1/assets/images/icon/search-icon.svg" alt="Submit" class="search-icon" value="Search">
</form>

POST /#wpcf7-f365-o1

<form action="/#wpcf7-f365-o1" method="post" class="wpcf7-form" novalidate="novalidate">
  <div style="display: none;">
    <input type="hidden" name="_wpcf7" value="365">
    <input type="hidden" name="_wpcf7_version" value="4.9.2">
    <input type="hidden" name="_wpcf7_locale" value="en_US">
    <input type="hidden" name="_wpcf7_unit_tag" value="wpcf7-f365-o1">
    <input type="hidden" name="_wpcf7_container_post" value="0">
  </div>
  <div class="newsletter_content">
    <span class="wpcf7-form-control-wrap email-id"><input type="email" name="email-id" value="" size="40" class="wpcf7-form-control wpcf7-text wpcf7-email wpcf7-validates-as-required wpcf7-validates-as-email email_class" id="email"
        aria-required="true" aria-invalid="false" placeholder="Email address"></span><button type="submit" aria-label="Name" class="wpcf7-submit news_btn"><svg xmlns="http://www.w3.org/2000/svg" width="14.991" height="14.611"
        viewBox="0 0 14.991 14.611">
        <path id="Icon_awesome-arrow-right" class="subscribe-arrow" data-name="Icon awesome-arrow-right"
          d="M6.374,3.626l.743-.743a.8.8,0,0,1,1.134,0l6.5,6.5a.8.8,0,0,1,0,1.134l-6.5,6.5a.8.8,0,0,1-1.134,0l-.743-.743a.8.8,0,0,1,.013-1.148l4.032-3.841H.8a.8.8,0,0,1-.8-.8V9.417a.8.8,0,0,1,.8-.8h9.616L6.387,4.773A.8.8,0,0,1,6.374,3.626Z"
          transform="translate(0 -2.647)" fill="#fff"></path>
      </svg></button><span class="ajax-loader"></span>
  </div>
  <div class="wpcf7-response-output wpcf7-display-none"></div><input type="hidden" name="vx_width" value="800"><input type="hidden" name="vx_height" value="600"><input type="hidden" name="vx_url" value="https://o2hdiscovery.co/">
</form>

Text Content

Skip to content


O2H DISCOVERY WEBSITE

o2h discovery – seeding new ideas in life science, tech and green …



 * about
   * company overview
   * team
   * ESG
   * o2h community
 * how we deliver
 * news
 * events
   * o2h Innovation Conference
   * Bootcamps
   * AIM squad
   * Cambridge Wide Open Day
   * Cambridge TechBIO Caucus
   * Biotech Bikers
   * o2h Chaitime Webinar
 * culture & careers
 * CITCTM
 * o2h group

 * integrated(drug discovery)
   * Target Identification and Validation
   * Hit Identification
   * Hit to Lead
   * Lead Optimization
   * Targeted protein degradation
   * Fragment-based Drug Discovery
   * Knowledge-based drug design and SAR
   * Early assessment of in vitro ADMET and PK
 * chemistry
   * medicinal chemistry
   * synthetic chemistry
   * PROTAC Services
   * Lipid Nanoparticles (LNPs)
   * analytical chemistry
   * ADCs – linker/payloads
   * o2h kickstarter competition
     * kickstarter, Australia
     * kickstarter, Israel
     * kickstarter, Italy
     * kickstarter, USA
     * kickstarter, Golden Partner
   * o2h fast pharma 18
 * biology
   * target engagement and validation
     * PROTAC
     * CETSA
     * NanoBRET/NanoBiT
     * CRISPR
     * siRNA/shRNA
     * Undruggable targets and genetic benchmarking
   * Assay biology
     * Biophysical
     * Biochemical
     * Cellular
     * Gene expression
     * Drug-Drug interactions and synthetic lethality
     * Biomarker assessment
     * Site-directed mutagenesis & binding studies
   * Drug Screening
     * Iterative screening
     * Primary, orthogonal and selectivity
     * Fragment-based screening
     * Phenotypic screening
 * DMPK
   * in-vitro ADME
   * in-vivo Pharmacokinetics (PK)
 * scale-up
   * kilo-lab
   * non-GMP
   * GMP [partnership]
 * catalog
 * contact

m:+91 8484 884 844 e:catalog@o2h.com o2h discovery
0
0
Get quote
 * m:+91 8484 884 844
 * e:catalog@o2h.com
 * o2h discovery
 * 0
 * 0
 * Get quote

Added successfully to RFQ list

Added successfully to compare list


BIOLOGY DELIVERED

We have a highly experienced team with a track record of delivering solid
results to progress challenging biology projects…

Know more


OBN AWARDS 2023

o2h discovery won the "Most Impactful CRO of the Year" Award at the industry
leading OBN Awards ceremony...

Know more


DISCOVERY DELIVERED

Insight driven science - a track record over a decade of breakthrough
innovations in people, process and technology to give you an outstanding drug
discovery services.

Know more


BIOLOGY DELIVERED

We have a highly experienced team with a track record of delivering solid
results to progress challenging biology projects…

Know more


OBN AWARDS 2023

o2h discovery won the "Most Impactful CRO of the Year" Award at the industry
leading OBN Awards ceremony...

Know more
 * 1
 * 2
 * 3


ABOUT O2H DISCOVERY

o2h discovery has an integrated drug discovery platform operating from its
state-of-the-art research centres in Ahmedabad, India and The Mill SciTech Park,
Cambridge, UK.

Know more


A PASSION FOR INNOVATION

Constantly innovating our people, project management and technology leading to
outstanding results for our collaborators.

DELIVERY MODEL

Our delivery model is designed for speed around effective project management,
processes/equipment and people. Delivery speed is at the very heart of all
project management at o2h discovery.

Know more


PEOPLE & CULTURE

The DNA of o2h group is centred around the nurturing of its people, values and
culture. It reflects in the way we work with each other, as well as our
collaborators and partners around the world.

Know more


CHEMISTRY IN THE CLOUD TM

o2h discovery’s innovative app Chemistry in the Cloud TM builds upon the latest
advances in secure cloud-based mobile technology and integrates project
management of external drug discovery programs.

Know more

white paper

EMBRACING GREEN AND SUSTAINABLE CHEMISTRY

The o2h discovery green chemistry model is designed to reduce and/or eliminate
the use and generation of hazardous substances and possess little or no toxicity
to human health and environment.

Download Whitepaper


SERVICES

a premier Contract Research Organisation providing integrated chemistry and
biology services for collaborative research.

INTEGRATED DRUG DISCOVERY

Integrated drug discovery service to help you take your idea from target
validation to pre-clinical candidate with a unique IP position.

CHEMISTRY

We are a premier service provider of mg/g scale discovery chemistry and have
partnered with a range of well known pharma and biotech companies.

BIOLOGY

We have a highly experienced team of biologists with a track record of
delivering solid results to progress challenging biology projects.

DMPK

We have a highly qualified team to investigate the metabolism of your compounds
with scientific rigor and an innovative flexible points system.

SCALE-UP

We have the capabilities and a specialised team with a broad array of experience
to support your non-GMP scale-up synthesis requirements.

SPECIALITY CHEMISTRY

We provide specialized chemistry services including PROTAC, LNP and Peptide
chemistry to name a few to meet your specific drug discovery needs.


COLLABORATORS

We have an extensive track record of collaborations and have supported marquee
pharma across the globe with up to 52 FTEs since 2004.

Brian Dymock

Head of QEDDI

Our relationship with o2h over many years supporting our medicinal chemistry
projects in QEDDI has been highly productive. With o2h’s help we have progressed
our portfolio to an advanced stage ready for partnering. We are very pleased
with the efficiency, productivity and communication with o2h chemists and look
forward to further positive outcomes.

Sharon Shacham

CEO & Managing Director

My relationship with o2h Discovery is now more than a decade. I have had many
opportunities to collaborate with the o2h team for my drug discovery efforts at
Karyopharm, Protai and Sporos Bioventures. I have always been impressed by their
efficiency to deliver novel chemical compounds that helps to achieve targeted
project milestones.

Prof Kirill Alexandrov

CSIRO-QUT Synthetic Biology Alliance

We have worked with o2h team on a range of synthetic projects and had
consistently positive experience .The combination of competence, effective
project management and detailed documentation made us go back again and again.
The company offers excellent value for money and makes a significant effort to
work within the given funding envelope.

Brian Dymock

Head of QEDDI

Our relationship with o2h over many years supporting our medicinal chemistry
projects in QEDDI has been highly productive. With o2h’s help we have progressed
our portfolio to an advanced stage ready for partnering. We are very pleased
with the efficiency, productivity and communication with o2h chemists and look
forward to further positive outcomes.

Sharon Shacham

CEO & Managing Director

My relationship with o2h Discovery is now more than a decade. I have had many
opportunities to collaborate with the o2h team for my drug discovery efforts at
Karyopharm, Protai and Sporos Bioventures. I have always been impressed by their
efficiency to deliver novel chemical compounds that helps to achieve targeted
project milestones.

View all


WHAT’S NEW?

Read about some of the most recent developments including research
collaborations at o2h discovery.

30 Sep 23

CITC WON THE “BEST USE OF TECHNOLOGY” AWARD IN PHARMA INDUSTRY AWARDS UK

29 Sep 23

MEET THE O2H KICKSTARTER EVALUATION COMMITTEE MEMBERS…

19 Sep 23

O2H KICKSTARTER 5.0 FOR EARLY STAGE USA BIOTECH


SUBSCRIBE TO RECEIVE UPDATES

Please sign up to receive latest updates and insights from the o2h discovery
frontline in India and UK.



o2h discovery private limited.


 * ABOUT
   
    * company overview
    * team
    * culture
    * ESG


 * SERVICES
   
    * Integrated Drug Discovery
    * Fragment-based Drug Discovery
    * Chemistry
    * In-vitro ADME


 * OTHER LINKS
   
    * news
    * Events
    * o2h community
    * contact

Visit o2h.com
 * 
 * 
 * 
 * 

Copyright © 2024  All rights reserved.



privacy policy